$3.5
Marker Therapeutics is a biotechnology business based in the US. Marker Therapeutics shares (MRKR) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $3.70 – an increase of 13.15% over the previous week. Marker Therapeutics employs 8 staff and has a trailing 12-month revenue of around $3.7 million.
What's in this guide?
Our top picks for where to buy Marker Therapeutics stock
- Trade options, futures, options on futures, stocks, ETFs
- $0 commission to close options
- Pro-grade platform and risk analysis tools
- Trade $0 commission stocks & ETFs with as little as $1
- Theme and ETF screener
- Discover new opportunities with Opto's AI-driven classification system
- Trade stocks, options, ETFs, mutual funds, alternative asset funds
- $0 commission on stocks, ETFs and options, with no options contract fees
- Complimentary access to a financial planner and automated investing
How to buy Marker Therapeutics stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – MRKR. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Marker Therapeutics stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Marker Therapeutics stock price (NASDAQ: MRKR)
Use our graph to track the performance of MRKR stocks over time.Marker Therapeutics shares at a glance
Latest market close | $3.70 |
---|---|
52-week range | $2.40 - $6.16 |
50-day moving average | $3.10 |
200-day moving average | $4.08 |
Wall St. target price | $11.75 |
PE ratio | N/A |
Dividend yield | N/A |
Earnings per share (TTM) | $-1.15 |
Is it a good time to buy Marker Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Marker Therapeutics price performance over time
Historical closes compared with the close of $3.52 from 2024-10-18
1 week (2024-10-15) | 7.65% |
---|---|
1 month (2024-09-20) | 19.73% |
3 months (2024-07-22) | -29.18% |
6 months (2024-04-22) | -15.99% |
1 year (2023-10-20) | 15.79% |
---|---|
2 years (2022-10-21) | 797.50% |
3 years (2021-10-22) | 144.44% |
5 years (2019-10-22) | 4.07 |
Marker Therapeutics financials
Revenue TTM | $3.7 million |
---|---|
Gross profit TTM | $-17,125,779 |
Return on assets TTM | -40.87% |
Return on equity TTM | -71.74% |
Profit margin | -278.22% |
Book value | $1.09 |
Market Capitalization | $33 million |
TTM: trailing 12 months
Marker Therapeutics share dividends
We're not expecting Marker Therapeutics to pay a dividend over the next 12 months.
Have Marker Therapeutics's shares ever split?
Marker Therapeutics's shares were split on a 1:10 basis on 26 January 2023 . So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Marker Therapeutics shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Marker Therapeutics shares which in turn could have impacted Marker Therapeutics's share price.
Marker Therapeutics share price volatility
Over the last 12 months, Marker Therapeutics's shares have ranged in value from as little as $2.4 up to $6.1568. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Marker Therapeutics's is 1.542. This would suggest that Marker Therapeutics's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Marker Therapeutics overview
Marker Therapeutics, Inc. , a clinical-stage immuno-oncology company, engages in the development and commercialization of novel T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications. Its multi tumor associated antigen-specific T cell technology is based on the manufacture of non-engineered tumor-specific T cells that recognize multiple tumor-associated antigens. The company also develops MT-401-OTS for the treatment of acute myeloid leukemia; and MT-601 to treat lymphoma and pancreatic cancer. Marker Therapeutics, Inc. is headquartered in Houston, Texas. .
Frequently asked questions
What percentage of Marker Therapeutics is owned by insiders or institutions?Currently 12.199% of Marker Therapeutics shares are held by insiders and 22.624% by institutions. How many people work for Marker Therapeutics?
Latest data suggests 8 work at Marker Therapeutics. When does the fiscal year end for Marker Therapeutics?
Marker Therapeutics's fiscal year ends in December. Where is Marker Therapeutics based?
Marker Therapeutics's address is: 9350 Kirby Drive, Houston, TX, United States, 77054 What is Marker Therapeutics's ISIN number?
Marker Therapeutics's international securities identification number is: US57055L1070 What is Marker Therapeutics's CUSIP number?
Marker Therapeutics's Committee on Uniform Securities Identification Procedures number is: 876033200
More guides on Finder
-
Fundamental Analysis
Fundamental analysis of stocks can help you become a better investor and find the true value of stocks and other assets.
-
Best Stocks for Beginners With Little Money to Invest
These are the stocks to buy when you don’t have much to spend.
-
Today’s Best Brokerage Account Bonuses [Signup and Transfer Promos]
Explore the best bonuses for opening a new brokerage account.
-
5 best stock picking services of 2024
Compare the 5 best stock picking services, according to Finder’s analysis, and learn how to choose the best option for your needs.
-
eToro review 2024: Commission-free social trading and investing
eToro is a robust trading platform with an easy-to-use interface and no commissions on stocks and ETFs.
-
5 Top Graphene Stocks to Invest in Today
We’ve rounded up stats on some of the most popular graphene stocks, along with information on how they compare and how to invest.
-
Titan Review 2024: Wealth Management With a No-Advisory-Fee Robo-Advisor
Titan invest is a members-only automated platform best for hands-off investors looking to build wealth.
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
Wealthfront review: Low-cost automated and DIY investing
Learn about Wealthfront’s automated investing tools and services to see if it’s the right platform for you.
-
How to trade options
Read our beginner’s guide to trading options in the US.
Ask a question